Jonathan Biller Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Jonathan Biller is EVP and Chief Legal Officer of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 15,306 shares of VRTX, which is worth approximately $6.64 Million. The most recent transaction as insider was on Dec 03, 2025, when has been sold 347 shares (Common Stock) at a price of $449.0 per share, resulting in proceeds of $155,803. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.3K

13.06% 3M change

8.08% 12M change

Total Value Held $6.64 Million

Jonathan Biller Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 03 2025	SELL Open market or private sale	$155,803 $449.0 p/Share	347 Reduced 2.22%	15,306 Common Stock
Oct 02 2025	SELL Open market or private sale	$280,521 $404.21 p/Share	694 Reduced 4.25%	15,653 Common Stock
Oct 01 2025	SELL Payment of exercise price or tax liability	$503,600 $400.0 p/Share	1,259 Reduced 7.15%	16,347 Common Stock
Feb 18 2025	SELL Open market or private sale	$754,034 $455.06 p/Share	1,657 Reduced 8.6%	17,606 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$697,043 $463.46 p/Share	1,504 Reduced 7.24%	19,263 Common Stock
Feb 12 2025	BUY Grant, award, or other acquisition	-	4,437 Added 17.6%	20,767 Common Stock
Feb 11 2025	SELL Open market or private sale	$1,578,733 $459.87 p/Share	3,433 Reduced 17.37%	16,330 Common Stock

Feb 10 2025	SELL Payment of exercise price or tax liability	$763,743 $467.98 p/Share	1,632 Reduced 7.63%	19,763 Common Stock
Feb 04 2025	BUY Grant, award, or other acquisition	-	4,744 Added 18.15%	21,395 Common Stock
Oct 02 2024	SELL Open market or private sale	$461,198 $461.66 p/Share	999 Reduced 5.66%	16,651 Common Stock
Oct 01 2024	SELL Payment of exercise price or tax liability	$294,109 $466.84 p/Share	630 Reduced 3.45%	17,650 Common Stock
Feb 12 2024	SELL Open market or private sale	$727,822 $418.77 p/Share	1,738 Reduced 8.68%	18,280 Common Stock
Feb 09 2024	SELL Payment of exercise price or tax liability	$671,311 $422.74 p/Share	1,588 Reduced 7.35%	20,018 Common Stock
Feb 07 2024	BUY Grant, award, or other acquisition	-	4,743 Added 18.0%	21,606 Common Stock
Feb 06 2024	BUY Grant, award, or other acquisition	-	6,294 Added 27.18%	16,863 Common Stock
Oct 02 2023	SELL Open market or private sale	$211,523 $346.76 p/Share	610 Reduced 5.46%	10,569 Common Stock
Sep 29 2023	SELL Payment of exercise price or tax liability	$143,093 $350.72 p/Share	408 Reduced 3.52%	11,179 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	6,293 Added 35.2%	11,587 Common Stock
Sep 19 2022	BUY Grant, award, or other acquisition	-	5,294 Added 50.0%	5,294 Common Stock

Also insider at

AGIO

AGIOS PHARMACEUTICALS, INC. Healthcare

Chief Financial Officer

Jonathan Biller

EVP and Chief Legal Officer

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account